Quick Answer
Forte Biosciences, Inc. reported Operating Income of -$70.66 million for fiscal year 2025.
Forte Biosciences, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$70.66M | -93.0% |
| 2024 | -$36.60M | -12.7% |
| 2023 | -$32.49M | -133.8% |
| 2022 | -$13.90M | +35.3% |
| 2021 | -$21.49M | +53.6% |
| 2020 | -$46.28M | -1038.8% |
| 2019 | -$4.06M | +91.1% |
| 2018 | -$45.85M | -21.9% |
| 2017 | -$37.63M | -18.7% |
| 2016 | -$31.69M | -38.1% |
| 2015 | -$22.95M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$18.38M | -113.0% | -58.8% |
| June 30, 2025 | -$11.58M | +9.7% | +28.2% |
| March 31, 2025 | -$16.12M | -106.6% | -86.9% |
| September 30, 2024 | -$8.63M | +15.5% | +32.7% |
| June 30, 2024 | -$12.82M | -41.9% | -64.2% |
| March 31, 2024 | -$7.80M | -13.8% | +23.6% |
| September 30, 2023 | -$10.22M | -198.5% | -13.1% |
| June 30, 2023 | -$9.03M | -199.1% | -31.8% |
- Forte Biosciences, Inc. showed a decrease of -93.0% in Operating Income compared to the prior fiscal year.
- Over the 2015–2025 period, Forte Biosciences, Inc.’s operating income has declined by 207.8% (from -$22.95 million to -$70.66 million).
- The most recent figure is from Forte Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: